Literature DB >> 2855778

The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.

R A Neal1, J van Bueren, G Hooper.   

Abstract

Furazolidone and nitrofurazone showed in vitro activity against amastigotes of Leishmania donovani, L. enriettii and L. major in macrophages, at concentrations which were also toxic to the macrophages. A low grade of activity was observed against L. donovani infections in BALB/c mice by furazolidone but not with nitrofurazone. Nitrofurazone, in two concentrations, was not active when applied to the lesions of cutaneous leishmaniasis due to L. enriettii (guinea-pig infection) or L. major strain P (BALB/c mouse infection). After systemic administration to BALB/c mice infected with L. major strain JISH 252 clone 1, low-grade activity was observed at the highest level tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2855778     DOI: 10.1080/00034983.1988.11812275

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  4 in total

1.  Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study.

Authors:  Juliana Quero Reimão; Noemi Nosomi Taniwaki; André Gustavo Tempone
Journal:  Parasitol Res       Date:  2010-03-30       Impact factor: 2.289

Review 2.  Liposomal drug delivery systems for the treatment of leishmaniasis.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Regina Maia de Souza; Victoria Stadler Tasca Ribeiro; Valdir Sabbaga Amato
Journal:  Parasitol Res       Date:  2022-09-16       Impact factor: 2.383

3.  Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.

Authors:  Jair L Siqueira-Neto; Ok-Ryul Song; Hyunrim Oh; Jeong-Hun Sohn; Gyongseon Yang; Jiyoun Nam; Jiyeon Jang; Jonathan Cechetto; Chang Bok Lee; Seunghyun Moon; Auguste Genovesio; Eric Chatelain; Thierry Christophe; Lucio H Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

Review 4.  Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.

Authors:  Stephen Patterson; Susan Wyllie
Journal:  Trends Parasitol       Date:  2014-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.